Australia's largest stock trading and investment forum Australia's #1 stock forum

ACX

0.00%

$7.79 aconex limited

Yep that guidance was exactly what I believe they were trying to...

First 247 Last

Share
Profile

Follow
Just_a_guy

5,420 Posts.

298

23/10/16

21:04

Post #: 20063432
Share

Originally posted by Alex999 ↑

Guidance of "20-25% inclusive Conject" is actually guidance of 45-50% revenue growth this FY, which is fast by any standard. They're then guiding "20-25%" indefinitely after that. They would have done better just to say: "FY17 = $180-$187m = 45-50%. Constant currency."

The market is saying at these prices - same share price now as when Conject deal announced in March - they're going to miss guidance at bottom end range this FY, and not achieve even 20% p.a. after that. There is a slight headwind in the GBP decline against AUD since Brexit but this will effect costs as well as revenues and wash out.

Market saying now strategic and operational gains from Conject - nope. Network impact of Fluor enterprise and Mobil Exxon enterprise deals have been forgotten in doubt. Asian growth flagged at the Investor Day - forgotten. Worksite / cost control rollout (happening now) totally forgotten. Opportunities for other acquisitions / bolt-ons, forgotten too. It's sentiment rather than substance - but over the short term, 3-6 months, sentiment rules - see the chart.

Expand

Yep that guidance was exactly what I believe they were trying to say but they stumbled over their delivery of the numbers due to conject in the conference call. Funny how a tiny bit of market anxiety in a market darling can contribute to such a drop. Good for me as a net buyer in the long run though

ACX Price at posting: $5.35 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

AI stocks: What to expect in 2024-25

VMM

Virdis Mining flags breakthrough with 76% neodymium and praseodymium recoveries

Talking the US election, the spectre of Trump and what's hot on the ASX200: Wealth Within

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised